Beam Therapeutics's total assets for Q1 2025 were $1.47B, an increase of 32.89% from the previous quarter. BEAM total liabilities were $343.78M for the fiscal quarter, a -7.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.